Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial

DOI Full Paper Access

61

Citations

24

References

2011

Year

George Karanikolas, EFTYHIA-MARIA KOUKLI, Aikaterini Katsalira, Aikaterini Arida, Dimitrios Petrou, Eleni Komninou, Kalliopi Fragiadaki, Anna Zacharioudaki, IOANNIS LASITHIOTAKIS, Eirini Giavri,

The Journal of Rheumatology

Abstract

The combination of adalimumab and CYC is safe and seemed to produce major improvement in both clinical and serological variables in patients with severely active PsA and inadequate response to MTX.

References

	Year	Citations

Page 1